Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) Equity Average (2016 - 2025)

Milestone Scientific's Equity Average history spans 14 years, with the latest figure at $2.9 million for Q3 2025.

  • For Q3 2025, Equity Average fell 61.19% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $2.9 million, down 61.19%, while the annual FY2024 figure was $6.9 million, 23.16% down from the prior year.
  • Equity Average for Q3 2025 was $2.9 million at Milestone Scientific, down from $3.9 million in the prior quarter.
  • Across five years, Equity Average topped out at $18.3 million in Q2 2021 and bottomed at $2.9 million in Q3 2025.
  • The 5-year median for Equity Average is $8.5 million (2023), against an average of $10.3 million.
  • The largest annual shift saw Equity Average surged 1560.5% in 2021 before it tumbled 61.19% in 2025.
  • A 5-year view of Equity Average shows it stood at $16.1 million in 2021, then plummeted by 34.29% to $10.6 million in 2022, then decreased by 29.18% to $7.5 million in 2023, then fell by 13.0% to $6.5 million in 2024, then tumbled by 54.88% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Equity Average are $2.9 million (Q3 2025), $3.9 million (Q2 2025), and $5.1 million (Q1 2025).